0001209191-19-061842.txt : 20191223 0001209191-19-061842.hdr.sgml : 20191223 20191223193401 ACCESSION NUMBER: 0001209191-19-061842 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20191220 FILED AS OF DATE: 20191223 DATE AS OF CHANGE: 20191223 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Cappel Markus J. CENTRAL INDEX KEY: 0001422995 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35420 FILM NUMBER: 191307781 MAIL ADDRESS: STREET 1: 850 MAUDE AVENUE CITY: MOUNTAIN VIEW STATE: CA ZIP: 94043 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ChemoCentryx, Inc. CENTRAL INDEX KEY: 0001340652 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 943254365 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 850 MAUDE AVENUE CITY: MOUNTAIN VIEW STATE: CA ZIP: 94043 BUSINESS PHONE: 650-210-2900 MAIL ADDRESS: STREET 1: 850 MAUDE AVENUE CITY: MOUNTAIN VIEW STATE: CA ZIP: 94043 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2019-12-20 0 0001340652 ChemoCentryx, Inc. CCXI 0001422995 Cappel Markus J. C/O CHEMOCENTRYX, INC. 850 MAUDE AVENUE MOUNTAIN VIEW CA 94043 0 1 0 0 Chief Bus. Officer & Treasurer Common Stock 2019-12-20 4 M 0 3544 7.10 A 38985 D Common Stock 2019-12-20 4 M 0 12369 8.19 A 51354 D Common Stock 2019-12-20 4 M 0 12000 3.57 A 63354 D Common Stock 2019-12-20 4 M 0 2346 6.62 A 65700 D Stock Option (right to buy) 7.10 2019-12-20 4 M 0 3544 D 2024-02-19 Common Stock 3544 166456 D Stock Option (right to buy) 8.19 2019-12-20 4 M 0 12369 D 2025-02-23 Common Stock 12369 142631 D Stock Option (right to buy) 3.57 2019-12-20 4 M 0 12000 D 2026-03-07 Common Stock 12000 53000 D Stock Option (right to buy) 6.62 2019-12-20 4 M 0 2346 D 2027-02-28 Common Stock 2346 87654 D As of December 20, 2019, and prior to this transaction, the exercised options were fully vested. Not applicable. /s/ Susan M. Kanaya, as Attorney-in-Fact 2019-12-23